International Pharmaceuticals, Sharp Rise Again Today Following Yesterday's Limit-Up! Revealing Upcoming Follow-Up Stocks!

Last week’s free trial recommended stock, Kukje Pharm, surged again today following yesterday’s limit-up!!

Thank you for calmly following the lead even at the limit-up!!

Congratulations sincerely to everyone who applied for the trial and made profits today!!

▶▶This stock that foreigners and institutions are sweeping up today!! Now is the last buying timing [First-come, first-served disclosure]◀◀

Natural antibiotic lactoferrin’s excellence in COVID-19 prevention announced in a comprehensive scientific journal! Related stock Kukje Pharm surges continuously!

The all-time great follow-up stock to continue Kukje Pharm’s glory! Oral COVID-19 vaccine development nearing completion!

Undervalued stock eyed by foreigners and institutions with at least 500% potential rise! Now is the buying point. Hurry up!

● TOP3 Joa Pharm (034940): Expectations for the combination drug approved for COVID-19 treatment!

● TOP2 BioSolution (086820): Patent on lactoferrin culture fluid, expectations rise on news of effectiveness against COVID-19 Delta variant!

● TOP1 (**1***): Undervalued! Imminent rise! This stock! Free disclosure on a first-come, first-served basis! ▶Click◀

- We will show how much profit can be made even with free trial recommended stocks.

▶▶This stock that will surge even more than Kukje Pharm! Don’t miss this buying opportunity now! [First-come, first-served disclosure click!]◀◀

[Profit rate status by stock]

Samhwa Electric +69% profit

Cosmo Chemical +59% profit

Antrogen +63% profit

Cafe24 +47% profit

Dexter +60% profit

Hancom MDS +62% profit

Willbes +97% profit

Doosan Heavy Industries +140% profit

Hyundai Mipo Dockyard +61% profit

Youngwoo DSP +78% profit

KEPCO Engineering & Construction +150% profit

Company K +51% profit

Hyosung Advanced Materials +105% profit

Dongkoo Bio & Pharma +83% profit

Top 5 stocks of interest: KNN / Samhwa Networks / Hankook Flange / Phoenix Materials / Hanchang Industry

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.